230 related articles for article (PubMed ID: 6326330)
1. [Alternative complement pathway].
Jouvin MH; Kazatchkine M
Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
[TBL] [Abstract][Full Text] [Related]
2. [The alternative complement pathway].
Jouvin MH; Kazatchkine M
Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
4. [Alternative complement pathway (author's transl)].
Kazatchkine M; Nydegger U; Fearon DT
Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
[TBL] [Abstract][Full Text] [Related]
5. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein Cleaves C3 and Activates Complement.
Irmscher S; Döring N; Halder LD; Jo EAH; Kopka I; Dunker C; Jacobsen ID; Luo S; Slevogt H; Lorkowski S; Beyersdorf N; Zipfel PF; Skerka C
J Innate Immun; 2018; 10(2):94-105. PubMed ID: 29237166
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathway of complement.
Pangburn MK
Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
[No Abstract] [Full Text] [Related]
8. Solubilization of immune precipitates by six isolated alternative pathway proteins.
Fujita T; Takata Y; Tamura N
J Exp Med; 1981 Dec; 154(6):1743-51. PubMed ID: 6459396
[TBL] [Abstract][Full Text] [Related]
9. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
10. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
11. Complement alternative pathway activation in human nonalcoholic steatohepatitis.
Segers FM; Verdam FJ; de Jonge C; Boonen B; Driessen A; Shiri-Sverdlov R; Bouvy ND; Greve JW; Buurman WA; Rensen SS
PLoS One; 2014; 9(10):e110053. PubMed ID: 25299043
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
13. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
Joiner K; Sher A; Gaither T; Hammer C
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
[TBL] [Abstract][Full Text] [Related]
14. The alternative pathway of complement.
Pangburn MK; Müller-Eberhard HJ
Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
[No Abstract] [Full Text] [Related]
15. Regulation of C5 convertase activity by properdin, factors B and H.
Weiler JM
Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
[No Abstract] [Full Text] [Related]
16. Interactions between the alternative complement pathway and proteases of the coagulation system.
Kazatchkine MD; Jouvin MH
Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
[No Abstract] [Full Text] [Related]
17. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
Pangburn MK; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
[TBL] [Abstract][Full Text] [Related]
18. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
19. [Activation of the alternative pathway of human complement (author's transl)].
Kazatchkine M; Fischer E; Nydegger U
Ann Immunol (Paris); 1982; 133C(2):181-8. PubMed ID: 7051949
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
